• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Analysis reveals barriers to routine HIV testing in high-income…

Bioengineer.org by Bioengineer.org
January 27, 2018
in Headlines, Health, Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
HIV, the AIDS virus (yellow), infecting a human immune cell. Credit: Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

A new HIV Medicine study identified several barriers to routine HIV testing in emergency departments and acute medical units in the UK and US. For the study, investigators searched electronic databases for US and UK studies published between 2006 and 2015 that described the offer of HIV testing to adults. HIV testing coverage ranged from 10%-38% and 19%-26% while uptake levels were higher (70%-84% and 53%-75%) in the UK and US, respectively. Operational barriers such as lack of time, the need for training, and concerns about giving results and follow-up of HIV-positive results were reported. Patient-specific factors including female sex, old age, and low risk perception correlated with refusal of HIV testing. Factors that facilitated the offer of HIV testing were venous sampling (versus point-of-care tests), commitment of medical staff to HIV testing policy and support from local HIV specialist providers.

“The individual and public health benefits of early HIV diagnosis and prompt treatment are hampered by the unacceptably low rates of routine HIV testing in nonspecialist settings,” said lead author Dr. Ali Elgalib. “The barriers identified by our review lie more with providers rather than patients–they stem from staff fears about offering HIV testing due to perceived lack of knowledge about HIV.”

###

Media Contact

Penny Smith
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1111/hiv.12568

Share12Tweet7Share2ShareShareShare1

Related Posts

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

September 1, 2025

New Predictive Model for Postpartum Hemorrhage in Cesarean Cases

September 1, 2025

Novel ADC Targets Fucosyl-GM1 in Lung Cancer

September 1, 2025

AI-Powered Adaptive Tutoring for Moodle: A Breakthrough

September 1, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

New Predictive Model for Postpartum Hemorrhage in Cesarean Cases

Novel ADC Targets Fucosyl-GM1 in Lung Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.